Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J. Thompson, Jeffrey A. Cohen, Brenda Banwell et al.|The Lancet Neurology|2017Cited by 8k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third editionClare Walton, Peer Baneke, Rachel King et al.|Multiple Sclerosis Journal|2020Cited by 2.5k
Intracortical Lesions in Multiple Sclerosis: Improved Detection with 3D Double Inversion-Recovery MR ImagingJeroen J.G. Geurts, Jonas A. Castelijns, Petra J. W. Pouwels et al.|Radiology|2005Cited by 509
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trialDaniel D. Mikol, Bernard M.J. Uitdehaag, Frederik Barkhof et al.|The Lancet Neurology|2008Cited by 484
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosisSergio E. Baranzini, Jorge R. Oksenberg, Joanne Wang et al.|Human Molecular Genetics|2008Cited by 479